|Partial Close, 4/2010 ||$31.5M|
|Venture Round, 11/2012 ||$2.52M|
|Private Equity, 2/2013 |
Johnson & Johnson Development Corporation
OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.